Pre-existing interferon gamma conditions the lung to mediate early control of SARS-CoV-2

KL Hilligan, S Namasivayam, CS Clancy, PJ Baker… - BioRxiv, 2023 - biorxiv.org
Interferons (IFNs) are critical for anti-viral host defence. Type-1 and type-3 IFNs are typically
associated with early control of viral replication and promotion of inflammatory immune …

[HTML][HTML] Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2

KL Hilligan, S Namasivayam, CS Clancy… - Nature …, 2023 - nature.com
Abstract Type-1 and type-3 interferons (IFNs) are important for control of viral replication;
however, less is known about the role of Type-2 IFN (IFNγ) in anti-viral immunity. We …

[PDF][PDF] Insights on interferon-independent induction of interferon-stimulated genes shaping the lung's response in early SARS-CoV-2 infection

SD Cho, H Shin, S Kim, HJ Kim - Heliyon, 2023 - cell.com
While mRNA vaccine efficacy against the 2019 coronavirus disease (COVID-19) outbreak
remains high, research on antiviral innate immune responses in the early stages of infection …

Type I interferon signaling induces a delayed antiproliferative response in respiratory epithelial cells during SARS-CoV-2 infection

J Bragazzi Cunha, K Leix, EJ Sherman… - Journal of …, 2023 - Am Soc Microbiol
Disease progression during SARS-CoV-2 infection is tightly linked to the fate of lung
epithelial cells, with severe cases of COVID-19 characterized by direct injury of the alveolar …

[PDF][PDF] The interferon landscape along the respiratory tract impacts the severity of COVID-19

B Sposito, A Broggi, L Pandolfi, S Crotta, N Clementi… - Cell, 2021 - cell.com
Summary Severe coronavirus disease 2019 (COVID-19) is characterized by overproduction
of immune mediators, but the role of interferons (IFNs) of the type I (IFN-I) or type III (IFN-III) …

[HTML][HTML] Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patients

MJ Ramos-Benitez, JR Strich, S Alehashemi, S Stein… - medRxiv, 2022 - ncbi.nlm.nih.gov
Understanding early innate immune responses to coronavirus disease 2019 (COVID-19) is
crucial to developing targeted therapies to mitigate disease severity. Severe acute …

[PDF][PDF] Weak induction of interferon expression by SARS-CoV-2 supports clinical trials of interferon lambda to treat early COVID-19

TR O'Brien, DL Thomas, SS Jackson… - Clin Infect …, 2020 - researchgate.net
Coronavirus Disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus,
was first identified in the Hubei province of China in December 2019 and has now spread …

[HTML][HTML] Pin-pointing the key hubs in the IFN-γ pathway responding to SARS-CoV-2 infection

A Toro, S Lage-Vickers, J Bizzotto, F Vilicich, A Sabater… - Viruses, 2022 - mdpi.com
Interferon gamma (IFN-γ) may be potential adjuvant immunotherapy for COVID-19 patients.
In this work, we assessed gene expression profiles associated with the IFN-γ pathway in …

[PDF][PDF] Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses

A Banerjee, N El-Sayes, P Budylowski, RA Jacob… - IScience, 2021 - cell.com
Type I interferons (IFNs) are our first line of defense against virus infection. Recent studies
have suggested the ability of SARS-CoV-2 proteins to inhibit IFN responses. Emerging data …

Integrated Organ Immunity: Antigen-specific CD4-T cell-derived IFN-γ induced by BCG imprints prolonged lung innate resistance against respiratory viruses

A Lee, K Floyd, SY Wu, Z Fang, TK Tan, C Li, H Hui… - bioRxiv, 2023 - biorxiv.org
Bacille Calmette-Guérin (BCG) vaccination can confer non-specific protection against
heterologous pathogens. However, the underlying mechanisms remain mysterious. Here …